These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 24839939)

  • 1. Mixed-ligand mononuclear copper(II) complex: crystal structure and anticancer activity.
    Qin XY; Liu YN; Yu QQ; Yang LC; Liu Y; Zhou YH; Liu J
    ChemMedChem; 2014 Aug; 9(8):1665-71. PubMed ID: 24839939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer activity for targeting telomeric G-quadruplex and antiangiogenesis of a novel Ru(II)-Se complex.
    Wang L; Zheng C; Liu Y; Le F; Yang F; Qin X; Wang C; Liu J
    Biol Trace Elem Res; 2014 Feb; 157(2):175-82. PubMed ID: 24407979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypotoxic copper complexes with potent anti-metastatic and anti-angiogenic activities against cancer cells.
    Shi X; Chen Z; Wang Y; Guo Z; Wang X
    Dalton Trans; 2018 Apr; 47(14):5049-5054. PubMed ID: 29561011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiosemicarbazone Cu(II) and Zn(II) complexes as potential anticancer agents: syntheses, crystal structure, DNA cleavage, cytotoxicity and apoptosis induction activity.
    Shao J; Ma ZY; Li A; Liu YH; Xie CZ; Qiang ZY; Xu JY
    J Inorg Biochem; 2014 Jul; 136():13-23. PubMed ID: 24690556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed ligand copper(II) complexes of N,N-bis(benzimidazol-2-ylmethyl)amine (BBA) with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity.
    Loganathan R; Ramakrishnan S; Suresh E; Riyasdeen A; Akbarsha MA; Palaniandavar M
    Inorg Chem; 2012 May; 51(10):5512-32. PubMed ID: 22559171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and Structure of a Ternary Copper(II) Complex with Mixed Ligands of Diethylenetriamine and Picrate: DNA/Protein-Binding Property and In Vitro Anticancer Activity Studies.
    Shi YN; Zheng K; Zhu L; Li YT; Wu ZY; Yan CW
    J Biochem Mol Toxicol; 2015 May; 29(5):221-33. PubMed ID: 25652782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel C,N-Cyclometalated Benzimidazole Ruthenium(II) and Iridium(III) Complexes as Antitumor and Antiangiogenic Agents: A Structure-Activity Relationship Study.
    Yellol J; Pérez SA; Buceta A; Yellol G; Donaire A; Szumlas P; Bednarski PJ; Makhloufi G; Janiak C; Espinosa A; Ruiz J
    J Med Chem; 2015 Sep; 58(18):7310-27. PubMed ID: 26313136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenic activity of mononuclear copper(II) polypyridyl complexes for the treatment of cancers.
    Nagababu P; Barui AK; Thulasiram B; Devi CS; Satyanarayana S; Patra CR; Sreedhar B
    J Med Chem; 2015 Jul; 58(13):5226-41. PubMed ID: 26068145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing the copper(II) complexes cytotoxicity to cancer cells through bound to human serum albumin.
    Gou Y; Zhang Y; Qi J; Zhou Z; Yang F; Liang H
    J Inorg Biochem; 2015 Mar; 144():47-55. PubMed ID: 25573806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, characterization, and anticancer activity of two mixed ligand copper(ii) complexes by regulating the VEGF/VEGFR2 signaling pathway.
    Qin XY; Wang YN; Yang XP; Liang JJ; Liu JL; Luo ZH
    Dalton Trans; 2017 Dec; 46(47):16446-16454. PubMed ID: 29143014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A ruthenium(II) complex capable of inducing and stabilizing bcl-2 G-quadruplex formation as a potential cancer inhibitor.
    Zhang J; Yu Q; Li Q; Yang L; Chen L; Zhou Y; Liu J
    J Inorg Biochem; 2014 May; 134():1-11. PubMed ID: 24513610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient DNA cleavage mediated by mononuclear mixed ligand copper(II) phenolate complexes: the role of co-ligand planarity on DNA binding and cleavage and anticancer activity.
    Jaividhya P; Dhivya R; Akbarsha MA; Palaniandavar M
    J Inorg Biochem; 2012 Sep; 114():94-105. PubMed ID: 22841366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syntheses and crystal structures of tetracopper(II) complexes bridged by asymmetric N,N'-bis(substituted)oxamides: Molecular docking, DNA-binding and in vitro anticancer activity.
    Li XJ; Zheng K; Wang LD; Li YT; Wu ZY; Yan CW
    J Inorg Biochem; 2013 Nov; 128():97-107. PubMed ID: 23948578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ternary copper(II) complexes with amino acid chains and heterocyclic bases: DNA binding, cytotoxic and cell apoptosis induction properties.
    Ma T; Xu J; Wang Y; Yu H; Yang Y; Liu Y; Ding W; Zhu W; Chen R; Ge Z; Tan Y; Jia L; Zhu T
    J Inorg Biochem; 2015 Mar; 144():38-46. PubMed ID: 25555321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structures and anti-cancer properties of two binuclear copper complexes.
    Qin XY; Yang LC; Le FL; Yu QQ; Sun DD; Liu YN; Liu J
    Dalton Trans; 2013 Oct; 42(41):14681-4. PubMed ID: 24026617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro cytotoxic activities, DNA-, and BSA-binding studies of a new dinuclear copper(II) complex with N-[3-(dimethylamino)propyl]-N'-(2-carboxylatophenyl)-oxamide as ligand.
    Jiao J; Jiang M; Li YT; Wu ZY; Yan CW
    J Biochem Mol Toxicol; 2014 Feb; 28(2):47-59. PubMed ID: 24497175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folate-functionalized human serum albumin carrier for anticancer copper(II) complexes derived from natural plumbagin.
    Gou Y; Zhang Z; Qi J; Liang S; Zhou Z; Yang F; Liang H
    J Inorg Biochem; 2015 Dec; 153():13-22. PubMed ID: 26398432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study on potential antitumor mechanism of a novel Schiff base copper(II) complex: synthesis, crystal structure, DNA binding, cytotoxicity and apoptosis induction activity.
    Qiao X; Ma ZY; Xie CZ; Xue F; Zhang YW; Xu JY; Qiang ZY; Lou JS; Chen GJ; Yan SP
    J Inorg Biochem; 2011 May; 105(5):728-37. PubMed ID: 21463568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two water-soluble copper(II) complexes: synthesis, characterization, DNA cleavage, protein binding activities and in vitro anticancer activity studies.
    Lu J; Sun Q; Li JL; Jiang L; Gu W; Liu X; Tian JL; Yan SP
    J Inorg Biochem; 2014 Aug; 137():46-56. PubMed ID: 24803026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure of new tetracopper(II) complexes bridged by 2-{N'-[2-(dimethylamino)ethyl]oxamido}benzoate: DNA-binding and anticancer activity.
    Zheng YJ; Li XW; Li YT; Wu ZY; Yan CW
    J Photochem Photobiol B; 2012 Sep; 114():27-37. PubMed ID: 22704662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.